Investor visit to Smith & Nephew Endoscopy 20 August 2007 Smith & Nephew plc, (LSE: SN, NYSE: SNN), the global medical technology business, will be holding a visit for institutional investors and analysts at the global headquarters of the company's Endoscopy business in Boston, Massachusetts, on Tuesday 18 September 2007. The visit will be hosted by Chief Executive, David Illingworth, and Mike Frazzette, President of Smith & Nephew Endoscopy. During the visit guests will have the opportunity to meet senior management and receive presentations from the heads of the Endoscopy business. The main presentations of the event will be webcast live on Smith & Nephew's corporate website at www.smith-nephew.com and will begin at 1.15pm BST/7.15am CST/8.15am EST on Tuesday 18 September 2007. An archive of these presentations will be available on the website shortly after the close. Enquiries Julie Allen Tel: +44 (0) 20 7401 7646 Corporate Affairs Co-ordinator About us Smith & Nephew (LSE: SN.L; NYSE: SNN) is one of the world's leading medical device companies, specialising in Orthopaedic Reconstruction, Orthopaedic Trauma and Clinical Therapies, Endoscopy and Advanced Wound Management. Smith & Nephew is a global leader in arthroscopy and advanced wound management and is one of the leading global orthopaedics companies. Smith & Nephew is dedicated to helping improve people's lives. The company prides itself on the strength of its relationships with its surgeon and healthcare professional customers, with whom its name is synonymous with the highest standards of performance, innovation and trust. The company has over 9,600 employees and operates in 31 countries around the world, generating sales of $2.8 billion. Forward-Looking Statements This press release contains certain "forward-looking statements" within the meaning of the US Private Securities Litigation Reform Act of 1995. In particular, statements regarding expected revenue growth and trading margins discussed under "Outlook" are forward-looking statements as are discussions of our product pipeline. These statements, as well as the phrases "aim", "plan", "intend", "anticipate", "well-placed", "believe", "estimate", "expect", "target", "consider" and similar expressions, are generally intended to identify forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other important factors (including, but not limited to, the outcome of litigation, claims and regulatory approvals) that could cause the actual results, performance or achievements of Smith & Nephew, or industry results, to differ materially from any future results, performance or achievements expressed or implied by such forward-looking statements. Please refer to the documents that Smith & Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith & Nephew's most recent annual report on Form 20F, for a discussion of certain of these factors. All forward-looking statements in this press release are based on information available to Smith & Nephew as of the date hereof. All written or oral forward-looking statements attributable to Smith & Nephew or any person acting on behalf of Smith & Nephew are expressly qualified in their entirety by the foregoing. Smith & Nephew does not undertake any obligation to update or revise any forward-looking statement contained herein to reflect any change in Smith & Nephew's expectation with regard thereto or any change in events, conditions or circumstances on which any such statement is based. This information is provided by RNS The company news service from the London Stock Exchange
SMITH & NEPHEW PLC ANNOUNCES INVESTOR VISIT TO SN ENDO
| Source: Smith & Nephew PLC
London, UK--(Marketwire - August 20, 2007) -